Versant Capital Management’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
Versant Capital Management's ONC Position: Q3 2026 in Review
Versant Capital Management held its BeOne Medicines (ONC) position steady in Q3 2026 at 7 shares worth $2.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2575.
Versant Capital Management first reported a position in ONC in Q1 2023 and has held it in 6 quarters since. 325 funds tracked by Wall St. Rank hold ONC as of Q3 2026.
- Versant Capital Management held 7 shares of BeOne Medicines worth $2.56K as of Q3 2026.
- Versant Capital Management left its BeOne Medicines share count unchanged in Q3 2026.
- BeOne Medicines made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2575 holding.
- Versant Capital Management first reported a position in BeOne Medicines in Q1 2023 and has held it in 6 quarters since.
- 325 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.